MedPath

LAXCODYL

LAXCODYL

Discontinued
DIN Number

02201763

Drug Class

Human

Market Date

Jun 18, 1997

Company
HC

tanta pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02201763
AIG Number0101506002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB02 BISACODYL
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BISACODYLActive
Strength: 10 MG / SUP
Monograph: BISACODYL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.